PMID- 15586409 OWN - NLM STAT- MEDLINE DCOM- 20051115 LR - 20211203 IS - 1008-9292 (Print) IS - 1008-9292 (Linking) VI - 33 IP - 6 DP - 2004 Nov TI - [The active metabolite of leflunomide A771726 inhibits proliferation and collagen synthesis of hepatic stellate cell]. PG - 515-8, 528 AB - OBJECTIVE: To investigate the effect of the metabolite of leflunomide, A771726,on proliferation and collagen synthesis of hepatic stellate cell (HSC). METHODS: HSC and Kupffer cells were isolated from the rat liver by collagenase IV and pronase perfusion, and purified by density gradient separation. The effects of A771726 on cell proliferation and collagen synthesis were examined by 3H-thymidine and 3H-proline incorporation assays, respectively. The TGF-beta, TNF-alpha and IL-1 levels in Kupffer cell conditioned medium (KCCM) were determined by enzyme-linked immunosorbent assay (ELISA). RESULTS: HSC and Kupffer cells in rat liver were well separated. The KCCM of CCl4-injured rats had significant stimulation effect on proliferation and collagen synthesis of HSC in primary culture. Addition of A771726 (0.001-10 micromol/Lein HSC culture stimulated by KCCM significantly inhibited proliferation and collagen synthesis of HSC. Furthermore, the elevated TGF-beta, TNF-alpha and IL-1 levels in KCCM of CCl4-injured rats were significantly reduced in A771726 treatment groups. CONCLUSION: A771726 has markedly inhibitory effect on proliferation and collagen synthesis of HSC and secretion of TGF-beta,TNF-alpha and IL-1 from Kupffer cells. FAU - Yao, Hong-wei AU - Yao HW AD - Zhejiang Respiratory Drugs Research Laboratory of State Food and Drugs Administration of China, College of Medicine, Zhejiang University, Hangzhou 310031, China. FAU - Li, Jun AU - Li J FAU - Chen, Ji-qiang AU - Chen JQ FAU - Xu, Shu-yun AU - Xu SY LA - chi PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Zhejiang Da Xue Xue Bao Yi Xue Ban JT - Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences JID - 100927946 RN - 0 (Aniline Compounds) RN - 0 (Collagen Type I) RN - 0 (Crotonates) RN - 0 (Hydroxybutyrates) RN - 0 (Immunosuppressive Agents) RN - 0 (Interleukin-1) RN - 0 (Isoxazoles) RN - 0 (Nitriles) RN - 0 (Toluidines) RN - 0 (Transforming Growth Factor beta) RN - 1C058IKG3B (teriflunomide) RN - CL2T97X0V0 (Carbon Tetrachloride) RN - G162GK9U4W (Leflunomide) SB - IM MH - Aniline Compounds/*pharmacology MH - Animals MH - Carbon Tetrachloride MH - Cell Division/drug effects MH - Cells, Cultured MH - Collagen Type I/*biosynthesis MH - Crotonates MH - Hepatocytes/*cytology MH - Hydroxybutyrates/*pharmacology MH - Immunosuppressive Agents/pharmacology MH - Interleukin-1/metabolism MH - Isoxazoles/metabolism/*pharmacology MH - Kupffer Cells/cytology MH - Leflunomide MH - Male MH - Nitriles MH - Rats MH - Rats, Sprague-Dawley MH - Toluidines MH - Transforming Growth Factor beta/metabolism EDAT- 2004/12/09 09:00 MHDA- 2005/11/16 09:00 CRDT- 2004/12/09 09:00 PHST- 2004/12/09 09:00 [pubmed] PHST- 2005/11/16 09:00 [medline] PHST- 2004/12/09 09:00 [entrez] AID - 10.3785/j.issn.1008-9292.2004.06.010 [doi] PST - ppublish SO - Zhejiang Da Xue Xue Bao Yi Xue Ban. 2004 Nov;33(6):515-8, 528. doi: 10.3785/j.issn.1008-9292.2004.06.010.